Renfu Pharmaceutical announced that the company's shareholder China Merchants Life Technology Co., Ltd. and its co-actors plan to increase their holdings of the company within 6 months through legal compliance methods such as centralized bidding transactions and bulk transactions on the stock exchange. The cumulative increase ratio is not less than 1% or less than 2%. The maximum price for this increase is 25.53 yuan/share. The funding sources are own capital and special loans to increase share holdings. The increasing entity currently holds a total of 403 million shares of the company, accounting for 24.70% of the company's total share capital.

Zhitongcaijing · 07/02 10:01
Renfu Pharmaceutical announced that the company's shareholder China Merchants Life Technology Co., Ltd. and its co-actors plan to increase their holdings of the company within 6 months through legal compliance methods such as centralized bidding transactions and bulk transactions on the stock exchange. The cumulative increase ratio is not less than 1% or less than 2%. The maximum price for this increase is 25.53 yuan/share. The funding sources are own capital and special loans to increase share holdings. The increasing entity currently holds a total of 403 million shares of the company, accounting for 24.70% of the company's total share capital.